An open-label study of oral acetazolamide for the prevention of antipsychotic associated weight gain

BACKGROUND: Weight gain associated with atypical antipsychotic medications need to be well managed. We set out: 1. To test the effect of acetazolamide on weight gain associated with antipsychotics 2. To assess improvement in psychotic symptoms using the Brief Psychiatric Rating Scale score on patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Priyamkari, Anupama, Kakunje, Anil, Nimgaonkar, Vishwajit L., Deshpande, Smita, Bhatia, Triptish, Wood, Joel, Kini, Ganesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236665/
https://www.ncbi.nlm.nih.gov/pubmed/37274570
http://dx.doi.org/10.4103/ipj.ipj_5_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236665/
https://www.ncbi.nlm.nih.gov/pubmed/37274570
http://dx.doi.org/10.4103/ipj.ipj_5_22

Ejemplares similares